155 related articles for article (PubMed ID: 2901974)
1. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor.
Gross G; Hanft G; Rugevics C
Eur J Pharmacol; 1988 Jul; 151(2):333-5. PubMed ID: 2901974
[TBL] [Abstract][Full Text] [Related]
2. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Hanft G; Gross G
Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
[TBL] [Abstract][Full Text] [Related]
3. Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.
Sleight AJ; Koek W; Bigg DC
Eur J Pharmacol; 1993 Jul; 238(2-3):407-10. PubMed ID: 7691623
[TBL] [Abstract][Full Text] [Related]
4. Identification of alpha 1-adrenoceptor subtypes in the rat vas deferens: binding and functional studies.
Ohmura T; Oshita M; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Nov; 107(3):697-704. PubMed ID: 1361871
[TBL] [Abstract][Full Text] [Related]
5. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
[TBL] [Abstract][Full Text] [Related]
6. Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart.
Michel MC; Hanft G; Gross G
Br J Pharmacol; 1994 Feb; 111(2):533-8. PubMed ID: 7911718
[TBL] [Abstract][Full Text] [Related]
7. 5-Methylurapidil may discriminate between alpha 1-adrenoceptors with a high affinity for WB4101 in rat lung.
Hiramatsu Y; Muraoka R; Kigoshi S; Muramatsu I
Br J Pharmacol; 1992 Jan; 105(1):6-7. PubMed ID: 1350746
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
Sallés J; Badia A
Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.
Kenny BA; Naylor AM; Greengrass PM; Russell MJ; Friend SJ; Read AM; Wyllie MG
Br J Pharmacol; 1994 Apr; 111(4):1003-8. PubMed ID: 7913370
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
11. Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen.
Teng CM; Guh JH; Ko FN
Eur J Pharmacol; 1994 Nov; 265(1-2):61-6. PubMed ID: 7883030
[TBL] [Abstract][Full Text] [Related]
12. Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.
Gross G; Hanft G; Kolassa N
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):597-601. PubMed ID: 2832770
[TBL] [Abstract][Full Text] [Related]
13. Alpha 1-adrenoceptors: the ability of various agonists and antagonists to discriminate between two distinct [3H]prazosin binding sites.
Hanft G; Gross G; Beckeringh JJ; Korstanje C
J Pharm Pharmacol; 1989 Oct; 41(10):714-6. PubMed ID: 2575152
[TBL] [Abstract][Full Text] [Related]
14. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective binding of niguldipine enantiomers to alpha 1A-adrenoceptors labeled with [3H]5-methyl-urapidil.
Graziadei I; Zernig G; Boer R; Glossman H
Eur J Pharmacol; 1989 Oct; 172(4-5):329-37. PubMed ID: 2555206
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of alpha 1A- and alpha 1B-adrenoceptor binding sites in human brain tissue.
Gross G; Hanft G; Mehdorn HM
Eur J Pharmacol; 1989 Oct; 169(2-3):325-8. PubMed ID: 2572438
[TBL] [Abstract][Full Text] [Related]
17. Selectivity of benzodioxane alpha-adrenoceptor antagonists for alpha 1- and alpha 2-adrenoceptors determined by binding affinity.
Timmermans PB; van Kemenade JE; Batink HD; van Zwieten PA
Pharmacology; 1983; 26(5):258-69. PubMed ID: 6134295
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
19. Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.
Yamada S; Suzuki M; Kato Y; Kimura R; Mori R; Matsumoto K; Maruyama M; Kawabe K
Life Sci; 1992; 50(2):127-35. PubMed ID: 1370569
[TBL] [Abstract][Full Text] [Related]
20. Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
Kinami J; Tsuchihashi H; Maruyama K; Sasaki K; Nagatomo T
Jpn J Pharmacol; 1993 Feb; 61(2):81-6. PubMed ID: 7681491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]